Posted in | News | Gold

Southern Arc Minerals Obtains Assay Results from Mencanggah Prospect

Southern Arc Minerals has got the drilling results of the two primary holes from the Mencanggah prospect, which is located in the West Lombok project, Indonesia.

The target depth was not attained by the holes MCG001 and MCG002 when it was drilled at the Waterfall target and these holes have cut similar additional breccia formations and epithermal quartz vein.

The company has intersected 7.60 g/t gold over 0.80 m, 3.96 g/t gold over 2.30 m in the hole MCG001 and 9.80 g/t gold over 0.20 m, 5.15 g/t gold over 2.00 m in the hole MCG002.

Depending on the surface mapping program, the Waterfall target includes mineralized epithermal veins and breccias zone that is 1,200 m long and two major parallel formations, which are combined at depth based on the structural information.

The company has stopped drilling the holes MCG001 and MCG002 during August. It has enhanced the site protection and is anticipating the drilling continuation at the Mencanggah for analyzing the gold epithermal breccias by a drilling of around 30 holes to 300 m of average depth to finish 10,000 m totally by this year end. Southern Arc will carry on the follow-up drill program during the initial half of 2012 with an aim of finishing a NI 43-101 compliant resource calculation.

Southern Arc has intersected 1.0 g/t gold and 6.2 g/t silver over 1.35 m in the hole PLD028, 11.5 g/t gold over 0.85 m, 3.9 g/t gold over 3.90 m in the hole PLD031, 2.3 g/t gold over 3.30 m, 1.4 g/t gold over 13.15 m in the hole PLD032 and 1.04 g/t gold over 0.65 m in the PLD033 at the Pelangan prospect.

As a part of phase II campaign, the company has drilled over 7,000 m at the Pelangan prospect. It will commence around 13,000 m of drilling again at the Pelangan in the late fourth quarter in 2011 in an aim to finish a NI 43-101 compliant resource calculation for the Pelangan prospect.

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Southern Arc Minerals Inc.. (2019, February 18). Southern Arc Minerals Obtains Assay Results from Mencanggah Prospect. AZoMining. Retrieved on November 21, 2024 from https://www.azomining.com/News.aspx?newsID=5012.

  • MLA

    Southern Arc Minerals Inc.. "Southern Arc Minerals Obtains Assay Results from Mencanggah Prospect". AZoMining. 21 November 2024. <https://www.azomining.com/News.aspx?newsID=5012>.

  • Chicago

    Southern Arc Minerals Inc.. "Southern Arc Minerals Obtains Assay Results from Mencanggah Prospect". AZoMining. https://www.azomining.com/News.aspx?newsID=5012. (accessed November 21, 2024).

  • Harvard

    Southern Arc Minerals Inc.. 2019. Southern Arc Minerals Obtains Assay Results from Mencanggah Prospect. AZoMining, viewed 21 November 2024, https://www.azomining.com/News.aspx?newsID=5012.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.